91 related articles for article (PubMed ID: 2861992)
1. Pharmacokinetics of 14C-isotretinoin in healthy volunteers and volunteers with biliary T-tube drainage.
Colburn WA; Vane FM; Bugge CJ; Carter DE; Bressler R; Ehmann CW
Drug Metab Dispos; 1985; 13(3):327-32. PubMed ID: 2861992
[TBL] [Abstract][Full Text] [Related]
2. Effect of route of administration and biliary excretion on the pharmacokinetics of isotretinoin in the dog.
Cotler S; Chen S; Macasieb T; Colburn WA
Drug Metab Dispos; 1984; 12(2):143-7. PubMed ID: 6144477
[TBL] [Abstract][Full Text] [Related]
3. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of isotretinoin following a single oral dose.
Khoo KC; Reik D; Colburn WA
J Clin Pharmacol; 1982; 22(8-9):395-402. PubMed ID: 6957421
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of 14C-etretinate in healthy volunteers and two patients with biliary T-tube drainage.
Lucek RW; Dickerson J; Carter DE; Bugge CJ; Crews T; Vane FM; Cunningham W; Colburn WA
Biopharm Drug Dispos; 1988; 9(5):487-99. PubMed ID: 3066416
[TBL] [Abstract][Full Text] [Related]
6. Role of gut contents, intestinal wall, and liver on the first pass metabolism and absolute bioavailability of isotretinoin in the dog.
Cotler S; Buggé CJ; Colburn WA
Drug Metab Dispos; 1983; 11(5):458-62. PubMed ID: 6138231
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in humans.
Barbhaiya RH; Dandekar KA; Greene DS
Drug Metab Dispos; 1996 Jan; 24(1):91-5. PubMed ID: 8825195
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of isotretinoin. Biliary excretion of isotretinoin glucuronide in the rat.
Meloche S; Besner JG
Drug Metab Dispos; 1986; 14(2):246-9. PubMed ID: 2870901
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of hexachlorobenzene in male beagles. Distribution, excretion, and pharmacokinetic model.
Sundlof SF; Hansen LG; Koritz GD; Sundlof SM
Drug Metab Dispos; 1982; 10(4):371-81. PubMed ID: 6126337
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent pharmacokinetic profile of silvex following intravenous administration in rats.
Sauerhoff MW; Braun WH; LeBeau JE
J Toxicol Environ Health; 1977 Jan; 2(3):605-18. PubMed ID: 846008
[TBL] [Abstract][Full Text] [Related]
11. Metabolic disposition of simvastatin in patients with T-tube drainage.
Cheng H; Schwartz MS; Vickers S; Gilbert JD; Amin RD; Depuy B; Liu L; Rogers JD; Pond SM; Duncan CA
Drug Metab Dispos; 1994; 22(1):139-42. PubMed ID: 8149872
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and metabolism of vigabatrin following a single oral dose of [14C]vigabatrin in healthy male volunteers.
Durham SL; Hoke JF; Chen TM
Drug Metab Dispos; 1993; 21(3):480-4. PubMed ID: 8100505
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of o-nitroanisole in Fischer 344 rats.
Miller MJ; Sipes IG; Perry DF; Carter DE
Drug Metab Dispos; 1985; 13(5):527-31. PubMed ID: 2865097
[TBL] [Abstract][Full Text] [Related]
14. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile.
Balani SK; Xu X; Pratha V; Koss MA; Amin RD; Dufresne C; Miller RR; Arison BH; Doss GA; Chiba M; Freeman A; Holland SD; Schwartz JI; Lasseter KC; Gertz BJ; Isenberg JI; Rogers JD; Lin JH; Baillie TA
Drug Metab Dispos; 1997 Nov; 25(11):1282-7. PubMed ID: 9351905
[TBL] [Abstract][Full Text] [Related]
15. The disposition and metabolic fate of 14C-cibenzoline in man.
Massarella JW; Loh AC; Williams TH; Szuna AJ; Sandor D; Bressler R; Leinweber FJ
Drug Metab Dispos; 1986; 14(1):59-64. PubMed ID: 2868867
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of chlormadinone acetate following single and multiple oral dosing of chlormadinone acetate (2 mg) and ethinylestradiol (0.03 mg) and elimination and clearance of a single dose of radiolabeled chlormadinone acetate.
Terlinden R; Uragg H; Göhler K; Kneip C
Contraception; 2006 Sep; 74(3):239-44. PubMed ID: 16904418
[TBL] [Abstract][Full Text] [Related]
17. Metabolism and disposition of a potent and selective GABA-Aalpha2/3 receptor agonist in healthy male volunteers.
Polsky-Fisher SL; Vickers S; Cui D; Subramanian R; Arison BH; Agrawal NG; Goel TV; Vessey LK; Murphy MG; Lasseter KC; Simpson RC; Vega JM; Rodrigues AD
Drug Metab Dispos; 2006 Jun; 34(6):1004-11. PubMed ID: 16510541
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of 13-cis-retinoic acid in patients with advanced cancer.
Goodman GE; Einspahr JG; Alberts DS; Davis TP; Leigh SA; Chen HS; Meyskens FL
Cancer Res; 1982 May; 42(5):2087-91. PubMed ID: 7039822
[TBL] [Abstract][Full Text] [Related]
19. Excretion and metabolism of intramuscularly administered [14C]-haloperidol decanoate in rats.
Matsunaga Y; Nambu K; Oh-e Y; Miyazaki H; Hashimoto M
Arzneimittelforschung; 1986 Mar; 36(3):453-6. PubMed ID: 3707664
[TBL] [Abstract][Full Text] [Related]
20. Human metabolism of [1-methyl-14C]- and [2-14C]caffeine after oral administration.
Callahan MM; Robertson RS; Arnaud MJ; Branfman AR; McComish MF; Yesair DW
Drug Metab Dispos; 1982; 10(4):417-23. PubMed ID: 6126344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
